|
|
|
|
| Join Cell & Gene Live on October 16 at 11am ET for a virtual panel discussion on Designing Early Manufacturing for Long-Term Success in CGT. Registration is free with support from Thermo Fisher Scientific. |
|
|
|
|
On episode 112 of Cell & Gene: The Podcast, Michael Quigley, Ph.D., Chief Scientific Officer and Global Head of Research at Sanofi talks to Host Erin Harris about the establishment of Sanofi’s dedicated Genomic Medicine Unit (GMU). Dr. Quigley emphasizes in vivo delivery and process optimization to improve patient experience, scalability, and global access. |
|
|
|
| Remote Patient Monitoring Using Mobile Health Technology | White Paper | By Dominique G. Stuijt, Eva EM van Doeveren, et al., CHDR | Investigate the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment. |
|
|
|
| How AI Is Reshaping The Future Of Clinical Research | Article | By Cal Collins, OpenClinica | Artificial intelligence (AI) is rapidly transforming clinical research, with innovative applications in key areas such as real-world evidence generation, regulatory submissions, and biomarker discovery. |
|
|
| Phase 1 Clinical Trial Designs And Strategies | White Paper | By Kurt Preugschat, Precision for Medicine | With tailored guidance, sponsors can align their modern model-based and model-assisted design choices to program goals, accelerating progress while safeguarding patients. |
|
|
|
| Targeted Indication Selection Using Adaptive Design | Case Study | Veristat, Inc. | What is a Simon 2-stage design, and how was it used to enable each tumor-specific cohort in a Phase 2, multi-cohort oncology trial to be independently assessed for objective response rates? |
|
|
|
|
| As cell therapy programs progress into later clinical stages and regulatory scrutiny tightens, early analytical strategy has never been more important. At the 7th Cell Therapy Analytical Development Summit unite with your peers to build robust, predictive and compliant analytical frameworks that can withstand the next wave of analytical hurdles. See the new agenda. |
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
|
|
|
During this portion of our Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists, Pratik Jaluria, Ph.D., SVP Technical Development Strategy at BlueRock Therapeutics, Bruno Marques, Ph.D. VP, Process and Product Development at Century Therapeutics, and Kate Rochlin, Ph.D., COO at IN8bio continue the discussion on post-thaw processing, focusing on QC sampling and the challenges of scaling up automated thawing. |
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|
